BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 8359803)

  • 1. Obliteration of portal venules contributes to portal hypertension in biliary cirrhosis.
    Shan S; Zhao X; Wood-Trageser MA; Hu D; Liu L; Qi B; Jian J; Wang P; Lv W; Hu C
    J Pathol; 2024 Jun; 263(2):178-189. PubMed ID: 38551075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative Mechanisms and Cardiovascular Abnormalities of Cirrhosis and Portal Hypertension.
    Liu H; Nguyen HH; Hwang SY; Lee SS
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics.
    Gunarathne LS; Rajapaksha H; Shackel N; Angus PW; Herath CB
    World J Gastroenterol; 2020 Oct; 26(40):6111-6140. PubMed ID: 33177789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute kidney injury spectrum in patients with chronic liver disease: Where do we stand?
    Chancharoenthana W; Leelahavanichkul A
    World J Gastroenterol; 2019 Jul; 25(28):3684-3703. PubMed ID: 31391766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Barriers in Portopulmonary Hypertension.
    AbuHalimeh B; Krowka MJ; Tonelli AR
    Hepatology; 2019 Jan; 69(1):431-443. PubMed ID: 30063259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats.
    Chang CC; Lee WS; Hsieh HG; Chuang CL; Huang HC; Lee FY; Lee SD
    PLoS One; 2017; 12(6):e0179809. PubMed ID: 28632747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide and prostaglandin as mediators in the pathogenesis of hyperkinetic circulatory state in a model of endotoxemia-induced portal hypertension.
    Rizvi MR; Tauseef M; Shahid M; Babbar R; Fahim M; Sakhuja P; Sarin SK
    Hepatol Int; 2013 Jun; 7(2):622-35. PubMed ID: 26201795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous bacterial peritonitis: from pathophysiology to prevention.
    Bernardi M
    Intern Emerg Med; 2010 Oct; 5 Suppl 1():S37-44. PubMed ID: 20865473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of one week of carvedilol administration on cirrhotic rats.
    Lin HC; Huang YT; Wei HC; Yang YY; Lee TY; Wang YW; Hou MC; Lee SD
    J Gastroenterol; 2006 Apr; 41(4):361-8. PubMed ID: 16741616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular contractile response and signal transduction in endothelium-denuded aorta from cirrhotic rats.
    Lin HC; Yang YY; Huang YT; Lee TY; Hou MC; Lee FY; Lee SD
    World J Gastroenterol; 2005 Apr; 11(15):2306-12. PubMed ID: 15818743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of PGI2 in the formation and maintenance of hyperdynamic circulatory state of portal hypertensive rats.
    Wu ZY; Chen XS; Qiu JF; Cao H
    World J Gastroenterol; 2005 Feb; 11(5):752-5. PubMed ID: 15655838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids.
    Shah V; Haddad FG; Garcia-Cardena G; Frangos JA; Mennone A; Groszmann RJ; Sessa WC
    J Clin Invest; 1997 Dec; 100(11):2923-30. PubMed ID: 9389760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calcium antagonists on hepatic and systemic hemodynamics in awake portal hypertensive rats.
    Nagasawa M; Kawasaki T; Yoshimi T
    J Gastroenterol; 1996 Jun; 31(3):366-72. PubMed ID: 8726828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
    Oberti F; Sogni P; Cailmail S; Moreau R; Pipy B; Lebrec D
    Hepatology; 1993 Sep; 18(3):621-7. PubMed ID: 8359803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
    Cao H; Wu Z; Zhou J; Chen Z; Kuang Y
    Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for role of prostacyclin as a systemic hormone in portal hypertension.
    Sitzmann JV; Li SS; Adkinson NF
    Surgery; 1991 Feb; 109(2):149-53. PubMed ID: 1992548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced splanchnic vasoconstriction to angiotensin II in conscious rats with biliary cirrhosis.
    Braillon A; Cailmail S; Gaudin C; Lebrec D
    J Hepatol; 1993 Jan; 17(1):86-90. PubMed ID: 8445224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiology of the portal system and physiopathology of portal hypertension].
    Lebrec D
    Rev Prat; 1990 Jun; 40(16):1450-3. PubMed ID: 2193365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blocked suprahepatic pressure and the portohepatic gradient in evaluation of the portal circulation (author's transl)].
    Cortinovis A; Crippa A; Bellorini R; Pedroni G
    Chir Ital; 1980 Oct; 32(5):964-85. PubMed ID: 7018716
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.